One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases
doi : 10.1136/ard-2023-225371
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease
doi : 10.1136/ard-2024-225851
Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS–SPARTAN collaboration
doi : 10.1136/ard-2024-225882
Clinical information on imaging referrals for suspected or known axial spondyloarthritis: recommendations from the Assessment of Spondyloarthritis International Society (ASAS)
doi : 10.1136/ard-2024-226280
Paul Hunter Plotz (1937–2024): renaissance rheumatologist, human rights advocate and mensch
doi : 10.1136/ard-2024-226596
Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?
doi : 10.1136/ard-2024-225746
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial
doi : 10.1136/ard-2024-226024
Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis
doi : 10.1136/ard-2023-225306
Rheumatoid arthritis patients harbour aberrant enteric bacteriophages with autoimmunity-provoking potential: a paired sibling study
doi : 10.1136/ard-2024-225564
Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis
doi : 10.1136/ard-2023-224774
Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development
doi : 10.1136/ard-2024-226067
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
doi : 10.1136/ard-2024-225933
Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
doi : 10.1136/ard-2024-225854
Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease
doi : 10.1136/ard-2024-225853
Multiorgan involvement and circulating IgG1 predict hypocomplementaemia in IgG4-related disease
doi : 10.1136/ard-2024-225846
SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastase
doi : 10.1136/ard-2024-225645
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens
doi : 10.1136/ard-2024-226169
Serum from patients with idiopathic inflammatory myopathy induces skeletal muscle weakness
doi : 10.1136/ard-2024-225912
Ruxolitinib as a salvage therapy in adult-onset macrophage activation syndrome: insights from eight cases
doi : 10.1136/ard-2024-226433
Correction: AB0159 Health related quality of life among patients with rheumatoid arthritis at Tikur Anbessa specialized Hospital. A Hospital- based cross sectional study
